What's Another Name for Wegovy, and Why Does It Matter?

Step 1, Start with the molecule: semaglutide is the name underneath all of them

When a medicine gets to market, it travels under two names at once: the generic name for the active ingredient, and the brand name the manufacturer registers. For Wegovy, the generic name is semaglutide. Novo Nordisk makes semaglutide in several forms, and each form has its own brand. Understanding this is the fastest way to cut through the confusion that shows up on forums and social media.

Semaglutide works by mimicking GLP-1, a gut hormone released after eating. It signals to the brain that you're full, slows how quickly the stomach empties, and reduces appetite over time. That mechanism is the same across all semaglutide products. The differences lie in the dose, the delivery method, and (critically) the licence. The NHS medicines page for semaglutide sets out the basics clearly, and it's worth a quick read if you want the clinical picture in plain language. That's the one-minute check: look up semaglutide on the NHS site and you'll see every brand listed alongside what each is actually approved for.

None of this is splitting hairs. A patient who thinks Ozempic and Wegovy are interchangeable may end up on a dose or a product that isn't right for their situation, or sourced from a seller who's exploiting that confusion.

Step 2, Map the brands: Ozempic, Rybelsus and Wegovy side by side

There are three semaglutide products with UK authorisations. First, Ozempic (once-weekly injection, up to 2mg) is licensed for type 2 diabetes. It is not licensed for weight management in the UK. The fact that it causes weight loss as a side effect does not change this, and the MHRA is clear that GLP-1 medicines should not be used for cosmetic or quick weight loss outside their licensed indications. You can read more about how Wegovy and Ozempic compare and why the distinction matters for anyone looking specifically for weight management support.

Second, Rybelsus is an oral semaglutide tablet licensed for type 2 diabetes, available in 3mg, 7mg and 14mg strengths. It is not a weight-loss medicine. If you come across references to semaglutide tablets for weight loss, those are the Wegovy tablet, not Rybelsus, the doses and the licences are completely different.

Third, Wegovy (both the injection and the newer tablet) is licensed specifically for weight management. The injection (up to 2.4mg weekly, or the newer 7.2mg pen approved in April 2026) is for adults with a BMI of 30 or above, or 27 or above with a weight-related condition. The full Wegovy overview covers the injection's licensed doses and what the evidence shows.

Step 3 (The Wegovy tablet: the newest name in the semaglutide story

In June 2026, the MHRA approved oral semaglutide under the Wegovy name as the first GLP-1 weight-loss medicine in tablet form to be licensed in the UK) the UK was also the first country in Europe to approve it. The tablet schedule runs from 1.5mg daily up to a 25mg maintenance dose, taken first thing in the morning before food or drink. No refrigeration needed, which makes it a practical option for people who travel or who are uncomfortable with injections.

Trial data from the OASIS 4 study showed an average weight reduction of around 13.6% over 64 weeks compared to around 2.4% with placebo. Among participants who stayed fully adherent to treatment, average loss reached roughly 17%. Those figures come from a controlled trial setting; individual results vary, and a prescriber will help you understand what's realistic for your own circumstances. For a broader look at weight-loss treatment options, the weight-loss overview sets out how the different licensed medicines sit alongside each other.

One practical note on cost: because these are prescription-only medicines, any legitimate price you see should include clinical assessment and a prescription. There's more on where to source Wegovy safely and what to look for in a registered provider.

Step 4, What this means if you're looking for weight management treatment

The semaglutide brand names matter because only some of them are approved for weight loss. Seeking out Ozempic or Rybelsus for that purpose puts you outside the licensed indications and, if you're sourcing them online, potentially in contact with sellers who aren't operating through the regulated UK supply chain. The MHRA has warned repeatedly about counterfeit weight-loss pens sold online, some containing insulin rather than semaglutide, which carries serious risks.

If Wegovy is the right treatment for you, the legal route is a prescription following a clinical assessment. At nume, a GPhC-registered Independent Prescriber reads your consultation the same day, a real clinician, not automated software. Our pharmacy is registered with the General Pharmaceutical Council (registration number 9012878, verifiable at the GPhC register), and every treatment is dispensed through the licensed UK supply chain. If you'd like to explore what other name Wegovy goes by and why that matters when you're researching your options, that guide covers the detail clearly. Equally, if you're still asking yourself whether Wegovy has another name and what it means for your treatment, that page works through the question in full. If you'd like to compare how Wegovy sits alongside other weight-loss options before you decide, the Saxenda vs Wegovy comparison is a good place to continue reading. When you're ready to take the next step, start your free consultation and our prescribers will assess which treatment, if any, is right for you.